{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:03:42Z","timestamp":1780542222117,"version":"3.54.1"},"reference-count":2,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.1093\/ibd\/izag065","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:50:23Z","timestamp":1774615823000},"page":"1207-1207","source":"Crossref","is-referenced-by-count":0,"title":["Response to: The Long Game in Ulcerative Colitis: Mirikizumab\u2019s Four-Year Outcomes"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-8285","authenticated-orcid":false,"given":"David B","family":"Clemow","sequence":"first","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN, 46285,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026060322315816100_izag065-B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izag020","article-title":"The long game in ulcerative colitis: Mirikizumab\u2019s four-year outcomes","author":"Noviello","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026060322315816100_izag065-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izag007","article-title":"Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: final findings from the LUCENT-3 open-label extension study","author":"Sands","year":"2026","journal-title":"Inflamm Bowel Dis"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/6\/1207\/68089739\/izag065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/6\/1207\/68089739\/izag065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:32:09Z","timestamp":1780540329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/6\/1207\/8654941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":2,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag065","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,16]]}}}